Please ensure Javascript is enabled for purposes of website accessibility
More States Sue Opioid Maker Alleging Deceptive Marketing
gvw_ap_news
By Associated Press
Published 6 years ago on
June 4, 2019

Share

SACRAMENTO — California, Hawaii, Maine and the District of Columbia filed lawsuits Monday against the maker of OxyContin and the company’s former president, alleging the firm falsely promoted the drug by downplaying the risk of addiction while it emerged as one of the most widely abused opioids in the U.S.
The lawsuits were the latest by states and local governments against drugmaker Purdue Pharma as the country grapples with an opioid epidemic. About a dozen states have also targeted Richard Sackler, the company’s former leader, or members of his family.
“Purdue and the Sacklers traded the health and well-being of Californians for profit and created an unprecedented national public health crisis in the process,” California Attorney General Xavier Becerra said at a news conference announcing the legal action by his state. “We will hold them accountable.”
Becerra, echoing allegations lodged against Purdue Pharma by others attorneys general across the country, said the company falsely introduced OxyContin in the 1990s as a safe and effective treatment for chronic pain.
However, the California’s lawsuit alleges that Purdue and Sackler knew in 1997 that drugs containing oxycodone, such as OxyContin, were widely abused. Still, company representatives marketed it as not being addictive and downplayed the potential for abuse, the suit states.

Purdue Pharma Denied the Allegations

In a statement Monday, Purdue Pharma and former directors of the company denied the allegations and vowed to defend against the “misleading attacks.”

“Such allegations demand clear evidence linking the conduct alleged to the harm described. But we believe the state fails to show such causation and offers little evidence to support its sweeping legal claims.”spokesman Robert Josephson
It noted that OxyContin represents less than 2% of total opioid prescriptions and is still approved by the U.S. Food and Drug Administration for its intended use as a painkiller as prescribed by doctors and dispensed by pharmacists.
“Such allegations demand clear evidence linking the conduct alleged to the harm described,” spokesman Robert Josephson said in a statement. “But we believe the state fails to show such causation and offers little evidence to support its sweeping legal claims.”
A spokesman for Sackler did not immediately respond to a request for comment.
The family has faced a backlash in recent years amid a growing public outcry around opioid addiction. In addition, activists have targeted institutions, such as the Metropolitan Museum of Art, that the family has supported through large contributions. The museum has said it will no longer take money from members of the family linked to the drugmaker.
Purdue stopped marketing OxyContin to doctors last year. It settled a lawsuit by the state of Oklahoma in March for $270 million.
Photo of OxyContin pills
FILE – This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy, in Montpelier, Vt. Five state attorneys general announced lawsuits Thursday, May 16, 2019, seeking to hold the drug industry responsible for an opioid addiction crisis that has become the biggest cause of accidental deaths across the country and in many states. The new filings in Iowa, Kansas, Maryland, West Virginia and Wisconsin mean 45 states have now taken legal action in recent years against Purdue Pharma, the maker of OxyContin. Some of the states are also suing Richard Sackler, a former president and member of the family that owns the Connecticut-based firm. (AP Photo/Toby Talbot, File)

States Have Cracked Down on Doctors Who Overprescribe the Drug

The company previously said it is pursuing several options, including bankruptcy, which could upend pending litigation by states as well as about 2,000 local and tribal governments across the country.
The lawsuits filed Monday allege that Purdue Pharma pushed doctors to prescribe opioids for longer periods of time at higher doses.
“Our complaint alleges that their unrelenting sales visits to doctors and deceptive practices led to a marked increase in opioid prescriptions, and a corresponding increase in the number of Mainers suffering from opioid use disorder,” Maine Attorney General Aaron M. Frey said.
Maine’s lawsuit names Richard Sackler, Jonathan Sackler, Mortimer D.A. Sackler and Kathe Sackler — all of whom have served on the board of Stamford, Connecticut-based Purdue Pharma.
States have also cracked down on doctors who overprescribe the drug.
Hawaii Attorney General Clare Connors said in a statement Monday that she has filed lawsuits alleging violations of Hawaii’s Unfair and Deceptive Acts and Practices Law.

Maine Set a State Record for Total Drug Overdose Deaths in 2017

One complaint alleges Purdue deceptively marketed OxyContin and other opioids. Another says manufacturers and distributors sold more opioids than could be “legitimately prescribed.”

Opioids were involved in 47,600 overdose deaths in the U.S. in 2017, according to the agency. In 2017, it says, prescription opioids were involved in 1,172 overdose deaths in California; 100 overdose deaths in Maine; and 58 in the District of Columbia.
Meanwhile, the Centers for Disease Control and Prevention said opioids are the main driver of drug overdose deaths.
Opioids were involved in 47,600 overdose deaths in the U.S. in 2017, according to the agency. In 2017, it says, prescription opioids were involved in 1,172 overdose deaths in California; 100 overdose deaths in Maine; and 58 in the District of Columbia.
Maine set a state record for total drug overdose deaths in 2017 with 417.
Jordan Basileu joined Becerra in announcing California’s lawsuit. He said he was prescribed opioid painkillers at 18 following a car crash and became addicted.
“People think, ‘it’s from a doctor. How bad can it be?'” Basileu said of the drug.
Basileu said he overdosed four times before getting sober three years ago.
“I’m still cleaning up the mess that opioids got me in to,” he said.

DON'T MISS

Wired Wednesday: CEMEX’s New Mining Plan for the San Joaquin River

DON'T MISS

Trump Fires NSC Officials a Day After Far-Right Activist Raises Concerns to Him

DON'T MISS

China Halts Approvals for New US Investment Projects

DON'T MISS

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

DON'T MISS

Trump Tariff Fears Erase $2 Trillion From US Stocks

DON'T MISS

Startup Offers Controversial Microplastic Blood Cleansing Treatment

DON'T MISS

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

DON'T MISS

Politics Turns Ugly for a Conservative Running for Fresno State Student Body President

UP NEXT

Startup Offers Controversial Microplastic Blood Cleansing Treatment

UP NEXT

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

UP NEXT

No More Calling ‘Shotgun?’ CA Could Ban Teens From Riding in Front Seat

UP NEXT

Diehard Baseball Fans in Sacramento Welcome Athletics and Hope They Stay Awhile

UP NEXT

Flores Homers, Matos and Wade Also Go Deep to Help Giants Cap Sweep of Astros

UP NEXT

California’s Schools Chief Has a $200,000 Salary and a Side Gig

UP NEXT

Trump Proposes Tax Deduction for Auto Loan Interest on US-Made Cars

UP NEXT

Western US Sees Sharp Increase in Extreme Weather Impact

UP NEXT

7-Year-Old Girl Was Killed by a Falling Boulder at a Lake Tahoe Ski Resort

UP NEXT

Xavier Becerra Enters 2026 California Governor’s Race

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

7 hours ago

Trump Tariff Fears Erase $2 Trillion From US Stocks

8 hours ago

Startup Offers Controversial Microplastic Blood Cleansing Treatment

8 hours ago

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

9 hours ago

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

10 hours ago

Pence Will Receive the Profile in Courage Award From the JFK Library for His Actions on Jan. 6

11 hours ago

Politics Turns Ugly for a Conservative Running for Fresno State Student Body President

11 hours ago

Pentagon’s Watchdog to Review Hegseth’s Use of Signal App to Convey Plans for Houthi Strike

11 hours ago

President Trump’s Tariffs Could Be the Political Tipping Point

12 hours ago

Order That Kept Water in the Kern River Reversed by 5th District Court of Appeal

12 hours ago

Wired Wednesday: CEMEX’s New Mining Plan for the San Joaquin River

GV Wire’s Edward Smith talks with KMPH Fox 26 “Great Day” anchor Christina Rodriguez about the possibility of CEMEX digging a 600-foot hole ...

6 hours ago

6 hours ago

Wired Wednesday: CEMEX’s New Mining Plan for the San Joaquin River

President Donald Trump speaks during an event to announce new tariffs in the Rose Garden at the White House, Wednesday, April 2, 2025, in Washington. (AP/Mark Schiefelbein)
6 hours ago

Trump Fires NSC Officials a Day After Far-Right Activist Raises Concerns to Him

7 hours ago

China Halts Approvals for New US Investment Projects

7 hours ago

Measles Spreads to Central Texas; 5 States Have Active Outbreaks

8 hours ago

Trump Tariff Fears Erase $2 Trillion From US Stocks

8 hours ago

Startup Offers Controversial Microplastic Blood Cleansing Treatment

Dr. Mehmet Oz, President Donald Trump's pick to lead the Centers for Medicare and Medicaid Services, seated right, gives a thumbs-up alongside his wife Lisa Oz, seated left, with friends and family after he testified at his confirmation hearing before the Senate Finance Committee, on Capitol Hill in Washington, Friday, March 14, 2025. (AP/Ben Curtis)
9 hours ago

Senate Confirms Mehmet Oz to Take Lead of Medicare and Medicaid Agency

10 hours ago

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

Help continue the work that gets you the news that matters most.

Search

Send this to a friend